全球泛自闭症障碍诊断市场规模、份额、趋势和成长分析报告（2026-2034）

泛自闭症障碍诊断市场预计将从 2025 年的 389.6 亿美元成长到 2034 年的 597.1 亿美元，2026 年至 2034 年的复合年增长率为 4.86%。

由于人们对发展障碍的认识不断提高以及早期筛检工作的推进，全球泛自闭症障碍诊断市场正稳步扩张。泛自闭症障碍（ASD）在全球盛行率的上升是推动先进诊断工具需求的主要动力。早期诊断在提高介入措施的有效性方面发挥着至关重要的作用，从而进一步促进了市场成长。

成长要素包括神经影像技术的进步、基因检测技术的改进以及标准化行为评估工具的广泛应用。政府和非营利组织对早期儿童筛检计画的推广也促进了诊断率的提高。此外，儿童医疗保健服务的可近性提高也对市场产生了积极影响。

未来几年，人工智慧诊断平台与数位行为评估工具的整合有望提升诊断的准确性和效率。自闭症谱系障碍（ASD）相关遗传和神经因素研究的进展将推动技术创新。新兴地区医疗基础设施的扩建有望为参与企业创造新的成长机会。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球泛自闭症障碍诊断市场：依疾病分类

• 市场分析、洞察与预测
• 自闭症谱系障碍
• 亚斯伯格症候群
• 广泛性发展障碍（PDD）
• 其他的

第五章 全球泛自闭症障碍诊断市场：依服务类型划分

• 市场分析、洞察与预测
• 行为疗法
• 早期疗育
• 製药
• 其他的

第六章 全球泛自闭症障碍诊断市场：依机构划分

• 市场分析、洞察与预测
• 医院
• 教育咨商中心
• 其他的

第七章 全球泛自闭症障碍诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Jazz Pharmaceuticals
  • Axial Therapeutics
  • Dfusion Inc
  • Cognoa Inc
  • Johnson & Johnson
  • Novartis AG
  • Abbvie Inc
  • Curemark LLC
  • EarliTec Diagnostics Inc
  • Bristol Myers Squibb Co

The Autism Spectrum Disorder Diagnostics Market size is expected to reach USD 59.71 Billion in 2034 from USD 38.96 Billion (2025) growing at a CAGR of 4.86% during 2026-2034.

The Global Autism Spectrum Disorder Diagnostics Market is expanding steadily due to increasing awareness and early screening initiatives for developmental disorders. Rising prevalence of autism spectrum disorder (ASD) globally has significantly driven demand for advanced diagnostic tools. Early diagnosis plays a critical role in improving intervention outcomes, further strengthening market growth.

Growth drivers include advancements in neuroimaging techniques, genetic testing technologies, and standardized behavioral assessment tools. Government and non-profit initiatives promoting early childhood screening programs are contributing to higher diagnosis rates. Additionally, improved access to pediatric healthcare services is positively impacting the market.

In the coming years, integration of AI-based diagnostic platforms and digital behavioral assessment tools is expected to enhance accuracy and efficiency. Growing research into genetic and neurological factors associated with ASD will further support innovation. Expanding healthcare infrastructure in emerging regions will create additional growth opportunities for market participants.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Disease

• Autistic Disorder
• Asperger Syndrome
• Pervasive Development Disorder (PDD)
• Other

By Service

• Behavioural Approaches
• Early Intervention
• Medication
• Other

By Location

• Hospitals
• Education Counsellor Center
• Others

COMPANIES PROFILED

• Jazz Pharmaceuticals, Axial therapeutics, dfusion inc, Cognoa Inc, Johnson Johnson, Novartis AG, Abbvie Inc, Curemark LLC, EarliTec Diagnostics Inc, Bristol Myers Squibb Co
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET: BY DISEASE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Disease
• 4.2. Autistic Disorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Asperger Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pervasive Development Disorder (PDD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Behavioural Approaches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Early Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET: BY LOCATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Location
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Education Counsellor Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Disease
  • 7.2.2 By Service
  • 7.2.3 By Location
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Disease
  • 7.3.2 By Service
  • 7.3.3 By Location
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Disease
  • 7.4.2 By Service
  • 7.4.3 By Location
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Disease
  • 7.5.2 By Service
  • 7.5.3 By Location
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Disease
  • 7.6.2 By Service
  • 7.6.3 By Location
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Jazz Pharmaceuticals
  • 9.2.2 Axial Therapeutics
  • 9.2.3 Dfusion Inc
  • 9.2.4 Cognoa Inc
  • 9.2.5 Johnson & Johnson
  • 9.2.6 Novartis AG
  • 9.2.7 Abbvie Inc
  • 9.2.8 Curemark LLC
  • 9.2.9 EarliTec Diagnostics Inc
  • 9.2.10 Bristol Myers Squibb Co